283 related articles for article (PubMed ID: 23385052)
1. Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age.
Brambatti M; Guerra F; Matassini MV; Cipolletta L; Barbarossa A; Urbinati A; Marchesini M; Capucci A
Europace; 2013 May; 15(5):704-10. PubMed ID: 23385052
[TBL] [Abstract][Full Text] [Related]
2. Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival.
Manne M; Rickard J; Varma N; Chung MK; Tchou P
Pacing Clin Electrophysiol; 2013 Aug; 36(8):970-7. PubMed ID: 23718783
[TBL] [Abstract][Full Text] [Related]
3. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.
Gasparini M; Lunati M; Santini M; Tritto M; Curnis A; Bocchiardo M; Vincenti A; Pistis G; Valsecchi S; Denaro A;
Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of cardiac resynchronization therapy in very old patients: the Insync/Insync ICD Italian Registry.
Achilli A; Turreni F; Gasparini M; Lunati M; Sassara M; Santini M; Landolina M; Padeletti L; Puglisi A; Bocchiardo M; Orazi S; Perego GB; Valsecchi S; Denaro A
Europace; 2007 Sep; 9(9):732-8. PubMed ID: 17636304
[TBL] [Abstract][Full Text] [Related]
6. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results.
Pezzali N; Curnis A; Specchia C; Carubelli V; Covolo L; Donato F; Auricchio A; Regoli F; Metra M
Europace; 2013 Oct; 15(10):1475-81. PubMed ID: 23729404
[TBL] [Abstract][Full Text] [Related]
7. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
[TBL] [Abstract][Full Text] [Related]
8. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
[TBL] [Abstract][Full Text] [Related]
9. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
[TBL] [Abstract][Full Text] [Related]
10. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
11. Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians.
Verbrugge FH; Dupont M; De Vusser P; Rivero-Ayerza M; Van Herendael H; Vercammen J; Jacobs L; Verhaert D; Vandervoort P; Tang WH; Mullens W
Eur J Heart Fail; 2013 Feb; 15(2):203-10. PubMed ID: 23002114
[TBL] [Abstract][Full Text] [Related]
12. Atrial support pacing in heart failure: results from the multicenter PEGASUS CRT trial.
Martin DO; Day JD; Lai PY; Murphy AL; Nayak HM; Villareal RP; Weiner S; Kraus SM; Stolen KQ; Gold MR
J Cardiovasc Electrophysiol; 2012 Dec; 23(12):1317-25. PubMed ID: 22830441
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Left Ventricular Remodeling and Regional Dyssynchrony on Long-Term Prognosis after Cardiac Resynchronization Therapy.
Tayal B; Sogaard P; Delgado-Montero A; Goda A; Saba S; Risum N; Gorcsan J
J Am Soc Echocardiogr; 2017 Mar; 30(3):244-250. PubMed ID: 27986357
[TBL] [Abstract][Full Text] [Related]
14. CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy.
Paoletti Perini A; Bartolini S; Pieragnoli P; Ricciardi G; Perrotta L; Valleggi A; Vergaro G; Michelotti F; Boggian G; Sassone B; Mascioli G; Emdin M; Padeletti L
Europace; 2014 Jan; 16(1):71-80. PubMed ID: 23828875
[TBL] [Abstract][Full Text] [Related]
15. Revisiting diastolic filling time as mechanistic insight for response to cardiac resynchronization therapy.
Verbrugge FH; Verhaert D; Grieten L; Dupont M; Rivero-Ayerza M; De Vusser P; Van Herendael H; Reyskens R; Vandervoort P; Tang WH; Mullens W
Europace; 2013 Dec; 15(12):1747-56. PubMed ID: 23821473
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
[TBL] [Abstract][Full Text] [Related]
17. Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide QRS complex: a prospective study.
Fung JW; Zhang Q; Yip GW; Chan JY; Chan HC; Yu CM
J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1288-92. PubMed ID: 16987381
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold M; Abraham WT; Daubert JC;
Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
[TBL] [Abstract][Full Text] [Related]
20. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
